UCR provides publication management services for multinational clinical trials
as well as small research-related analyses.
We can help you:
-
Increase the visibility and impact of your study
Develop a publication strategy -
Simplify collaboration between authors
-
Ensure high-quality manuscripts
- Increase productivity
We offer an overall solution for the work process in accordance with Good Publication Practice (GPP3) guidelines. Since 2009, UCR has contributed to the publication of more than 190 scientific manuscripts and 220 abstracts.
UCR also offers a medical writing service for its clients,
including compilation of:
- Study protocols
- Patient Information
- Study reports
If you wish to write these documents yourself, we can review them, or provide advice and coaching.
Few Publications from 2025:
1. Oldgren J, Hijazi Z, Arheden H, Björkenheim A, Frykman V, Janzon M, Ravn-Fischer A, Renlund H, Själander A, Åkerfeldt T, Wallentin L. Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation – a Registry-based Multicenter Randomized Controlled Study. Circulation. 2025;0(0). doi: doi:10.1161/CIRCULATIONAHA.125.076725
2. Falkenberg M, James S, Andersson M, et al. Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial. Lancet. 2025. doi:10.1016/s0140-6736(25)01585-5.
3. Nordanstig J, James S, Andersson M, et al. Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial. Lancet. 2025. doi: 10.1016/S0140-6736(25)01584-3
4. Thelin S, Modrau IS, Duvernoy O, et al. No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial. Eur Heart J. 2025;46(18):1720-9. doi: 10.1093/eurheartj/ehaf018
5. James S, Erlinge D, Storey RF, et al. Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure. NEJM Evid. 2024;3(2):EVIDoa2300286. doi: 10.1056/EVIDoa2300286
6. Böhm F, Mogensen B, Engstrøm T, et al. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. N Engl J Med. 2024;390(16):1481-92. doi: 10.1056/NEJMoa2314149
7. Oldgren J, Åsberg S, Hijazi Z, et al. Early Versus Delayed Non-Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study. Circulation. 2022;146(14):1056-66. doi: 10.1161/circulationaha.122.060666